Poolbeg Pharma Share Price | |
---|---|
Price | 11.45 |
Bid | 11.30 |
Ask | 11.60 |
Change | 0.20 (1.72%) |
Volume | 1,124,202 |
Open | 11.65 |
High | 11.80 |
Low | 11.80 |
Prev. Close | 11.60 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 500.00m |
Market Capitalisation | £59.00m |
Market Size | 30,000 |
52 Week High | 11.90 |
52 Week High Date | 24-Apr-2024 |
52 Week Low | 6.38 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 42 |
---|---|
Vol. Sold | 562,475 |
Sold Value | £64.71k |
Vol. Bought | 261,727 |
Bought Value | £30.59k |
PE Ratio | -12.55319 |
Earnings | -0.94 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 15:39:32 | 11.303 | 300,000 | Unknown* | 11.30 | 11.60 | 33.91k | O Ordinary Delayed publication |
26-Apr-24 | 16:35:06 | 11.80 | 24,622 | Buy* | 11.30 | 11.60 | 2,905 | UT Uncrossing Trade |
26-Apr-24 | 16:29:37 | 11.60 | 8 | Buy* | 11.30 | 11.60 | 0.93 | O Ordinary Trade was executed as an SI |
26-Apr-24 | 16:28:34 | 11.5175 | 9,018 | Buy* | 11.30 | 11.60 | 1,039 | O Ordinary |
26-Apr-24 | 16:28:09 | 11.444 | 50,000 | Sell* | 11.30 | 11.60 | 5,722 | O Ordinary |
26-Apr-24 | 16:23:24 | 11.444 | 1,206 | Sell* | 11.30 | 11.60 | 138.01 | O Ordinary |
26-Apr-24 | 16:12:35 | 11.4225 | 9,200 | Sell* | 11.30 | 11.60 | 1,051 | O Ordinary |
26-Apr-24 | 16:08:08 | 11.444 | 11,281 | Sell* | 11.30 | 11.60 | 1,291 | O Ordinary |
26-Apr-24 | 15:53:47 | 11.445 | 38,572 | Sell* | 11.30 | 11.60 | 4,415 | O Ordinary |
26-Apr-24 | 15:26:00 | 11.60 | 4,310 | Buy* | 11.30 | 11.60 | 499.96 | O Ordinary Trade was executed as an SI |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
22-Feb-24 | 21-Feb-24 | Buy | Jeremy Skillington held the position of CEO at the time of this trade.Jeremy Skillington | 10.80 | GBX | 154,764 | 1,028,261 |
19-Feb-24 | 19-Feb-24 | Buy | Cathal Friel held the position of Executive Chairman at the time of this trade.Cathal Friel | 11.68 | GBX | 830,000 | 37,219,757 |
06-Oct-22 | 05-Oct-22 | Buy | Jeremy Skillington held the position of CEO at the time of this trade.Jeremy Skillington | 4.78 | GBX | 718,733 | 718,733 |
19-Jul-21 | 19-Jul-21 | Notification of Holding | Patrick J Ashe held the position of Independent Non-Executive Director at the time of this trade.Patrick J Ashe | 0.00 | 0 | 263,147 | |
19-Jul-21 | 19-Jul-21 | Notification of Holding | Cathal Friel held the position of Non-Executive Chairman at the time of this trade.Cathal Friel | 0.00 | 0 | 36,389,757 |
Welcome to Poolbeg Pharma plc which is listed on AIM (AIM:POLB). Keep up to date with our performance & latest news